annb0t
Top 20
Market forces rained on the parade of Medical Developments International Limited (ASX:MVP) shareholders today, when the analysts downgraded their forecasts for this year. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative. At AU$3.88, shares are up 9.3% in the past 7 days. Investors could be forgiven for changing their mind on the business following the downgrade; but it's not clear if the revised forecas...
>>> Read more: The Medical Developments International Limited (ASX:MVP) Analysts Have Been Trimming Their Sales Forecasts
>>> Read more: The Medical Developments International Limited (ASX:MVP) Analysts Have Been Trimming Their Sales Forecasts